Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
Sponsored Content
This content was paid for by an advertiser and created in collaboration with Crain's Custom Content.
December 10, 2015 11:00 PM

At the Heart of Treatment: Therapeutic Approaches

  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Srijoy Mahapatra

    Vice President, Clinical Medical and Scientific Affairs at St. Jude Medical

    An estimated 2.7 million Americans have the heart rhythm disorder atrial fibrillation (AF), and that number is expected to rise as the population ages. Cardiologist Dr. Srijoy Mahapatra, vice president of clinical, medical and scientific affairs at St. Jude Medical, talks about emerging strategies to manage the condition.

    What is the impact of atrial fibrillation?

    In the U.S., the incidence of atrial fibrillation (AF) and associated conditions is expected to grow as the population ages.2 Treatment of AF contributes to the ever-growing costs of health care, particularly costs associated with hospitalizations.3,4 Compounding the challenge, the condition has been associated with increased risk for stroke, heart failure and death, all of which increase in frequency and severity as patients grow older.

    How are AF patients currently treated?

    Treatment for AF and associated conditions begins at diagnosis, with a treatment plan, lifestyle modifications, and often, medication. Medication also plays an important role in disease management through heart rate and rhythm control; however, currently available medications treat AF symptoms and not the root cause of the condition. St. Jude Medical has developed a comprehensive portfolio of therapeutic approaches to provide physicians multiple treatment options for patients.

    What other types of treatment options are available for patients with AF?

    Ablation can be an effective treatment option that targets the underlying causes of heart rhythm disorders. Performed via a minimally invasive procedure, ablation alters tissue inside the heart where the irregular beats are triggered. Recent clinical trial data show that ablation using St. Jude Medical catheter contact force technology is safe and effective for patients with AF.5 St. Jude Medical has also developed cardiac mapping technology to support complex ablation procedures while reducing procedure times.

    What solutions does St. Jude Medical have to treat AF?

    At St. Jude Medical, we've designed solutions not just for AF, but for the condition's comorbidities, including heart failure. For people suffering from the earliest stages of heart failure, St. Jude Medical can offer a complete line of arrhythmia management, cardiac resynchronization therapy (CRT), and mechanical circulatory support in addition to solutions for AF.

    This includes:

    The St. Jude Medical TactiCathTM Quartz Contact Force Ablation Catheter provides physicians with an innovative solution designed to improve outcomes, efficiency and productivity during electrophysiology procedures worldwide. Catheter provides physicians with an innovative solution designed to improve outcomes, efficiency and productivity during electrophysiology procedures worldwide.6

    Our EnSite™ Cardiac Mapping System supports physicians during both contact force and non-contact force ablation procedures by creating three-dimensional models that are based on the anatomy of the patient's own cardiac chamber.

    In addition to our complete line of comprehensive arrhythmia management and cardiac resynchronization therapy (CRT) devices, the CardioMEMS™ HF System is the first and only FDA-approved heart failure monitoring device that, when managed by a physician, has been proven to significantly reduce hospital admissions and improve quality of life in NYHA class III HF patients who have been hospitalized in the previous 12 months. The CardioMEMS HF System and St. Jude Medical's left ventricular assist technology is transforming patient outcomes and altering patient and physician experiences with heart failure.


    ST. JUDE MEDICAL is a market leader in the research, design and development of electrophysiology and interventional cardiology solutions for pediatric patients worldwide. As a global medical device manufacturer, we are dedicated to transforming the treatment of some of the world's most expensive epidemic diseases by developing cost-effective medical technologies that save and improve lives. For more information, please visit SJM.com or follow us on Twitter @StJudeMedical.

    For More Information

    Visit SJM.com/AfibAnswers

    It's important to note that surgical procedures involve risk. Potential adverse events associated with ablation procedures include, but are not limited to, cardiovascular related complications, such as hematoma, effusion and infection. More serious complications or death are possible, though rare. Potential adverse events associated with the implantation of the CardioMEMS HF System include, but are not limited to, infection, arrhythmias, bleeding, hematoma, thrombus, myocardial infarction, transient ischemic attack, stroke, death and device embolization. Patients are advised to talk to their physician to understand all indications and contraindications for any St. Jude Medical device.

    The TactiCath™ Quartz Contact Force Ablation Catheter is indicated for use in cardiac electrophysiological mapping and for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used in conjunction with a compatible RF generator and three-dimensional mapping system. The system is contraindicated for patients who have had certain recent heart surgery; prosthetic valves; active systemic infection; use in coronary vasculature; myxoma or intracardiac thrombus, or an interatrial baffle or patch; retrograde trans-aortic approach in patients with aortic valve replacement.

    The CardioMEMS HF System is indicated for wirelessly measuring and monitoring pulmonary artery pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients who have been hospitalized for heart failure in the previous year. The system is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.

    Source / Reference

    1. CDC Atrial Fibrillation Fact Sheet available at: http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm

    2. CDC Atrial Fibrillation Fact Sheet available at: http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm

    3. and 4. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006;9(5):348-356.

    Kim MH, Klingman D, Lin J, Pathak P, Battleman DS. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation. Ann Pharmacother. 2009;43(5):840-848.

    5. http://media.sjm.com/newsroom/news-releases/news-releases-details/2014/St-Jude-Medical-Announces-TOCCASTAR/default.aspx

    6. Albenque et al. - Interest Of Real-time Contact Force Sensing For Pulmonary Vein Isolation - Mid-term outcome After Paroxysmal Atrial Fibrillation Catheter Ablation. P532, Heart Rhythm Society 2013

    Berkowitsch et al. - Clinical success of conventional vs. contact force-controlled radiofrequency catheter ablation of atrial fibrillation: outcome after 12 months. , 5845 ESC Amsterdam 2013

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing